Skip to main content

Peer Review reports

From: Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case report

Original Submission
13 Jul 2021 Submitted Original manuscript
2 Aug 2021 Reviewed Reviewer Report - naouel Dhouib
26 Nov 2021 Reviewed Reviewer Report - Ahmet Emre Eşkazan
1 Dec 2021 Reviewed Reviewer Report - Research Square Reviewer 1
4 Feb 2022 Author responded Author comments - Bai-Yan Wang
Resubmission - Version 2
4 Feb 2022 Submitted Manuscript version 2
15 Feb 2022 Reviewed Reviewer Report - Ahmet Emre Eşkazan
15 Feb 2022 Reviewed Reviewer Report - Research Square Reviewer 1
23 Feb 2022 Author responded Author comments - Bai-Yan Wang
Resubmission - Version 3
23 Feb 2022 Submitted Manuscript version 3
7 Mar 2022 Reviewed Reviewer Report - Research Square Reviewer 1
18 Mar 2022 Author responded Author comments - Bai-Yan Wang
Resubmission - Version 4
18 Mar 2022 Submitted Manuscript version 4
18 Apr 2022 Reviewed Reviewer Report - Research Square Reviewer 1
29 Apr 2022 Author responded Author comments - Bai-Yan Wang
Resubmission - Version 5
29 Apr 2022 Submitted Manuscript version 5
22 May 2022 Reviewed Reviewer Report - Research Square Reviewer 1
3 Oct 2022 Author responded Author comments - Bai-Yan Wang
Resubmission - Version 6
3 Oct 2022 Submitted Manuscript version 6
Publishing
4 Oct 2022 Editorially accepted
11 Dec 2022 Article published 10.1186/s13256-022-03636-9

You can find further information about peer review here.

Back to article page